ArticleBMJ open2022

Targeting the reduction of inflammatory risk associated with cardiovascular disease by treating periodontitis either alone or in combination with a systemic anti-inflammatory agent: protocol for a pilot, parallel group, randomised controlled trial.

Shalinie King et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.